David Iyú

Cardiac Glycosides as Novel Cancer Therapeutic Agents

Ticagrelor

Oleandrin induces apoptosis in human, but not in murine cells: Dephosphorylation of Akt, expression of FasL, and alteration of membrane fluidity

Highly Stereoselective Biocatalytic Synthesis of Key Cyclopropane Intermediate to Ticagrelor

Store‐operated calcium entry in vascular smooth muscle

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

CD39 and CD73 in immunity and inflammation

Ticagrelor: a P2Y₁₂antagonist for use in acute coronary syndromes

Ecto-5′-Nucleotidase: A Candidate Virulence Factor in Streptococcus sanguinis Experimental Endocarditis

Peri/Epicellular Thiol Oxidoreductases as Mediators of Extracellular Redox Signaling

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Physiology of Microglia

Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rats

Reduced capacitative calcium entry in the mesenteric vascular bed of bile duct-ligated rats

Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation

Mode of action of P2Y12 antagonists as inhibitors of platelet function

P2Y₁₂and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP

Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y ₁₂ Antagonist